ASA Advises Monitoring for Exhaled Carbon Dioxide During Upper GI Procedures

The American Society of Anesthesiologists’ Ambulatory Surgical Care committee issued a statement, advising anesthesiologists to consider monitoring patients for exhaled carbon dioxide in procedures using propofol, especially involving the upper GI tract.

Advertisement

The ASA’s statement reads:

“Monitoring for exhaled carbon dioxide should be considered during endoscopic procedures in which sedation is provided with propofol alone or in combination with opioids and/or benzodiazepines, and especially during these procedures on the upper gastrointestinal tract. Careful attention to airway management must be provided during endoscopic retrograde cholangiopancreaticography (ERCP) procedures performed in the prone position where ventilatory monitoring, airway maintenance, and resuscitation may be especially difficult.”

Learn more about the ASA.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Patient Safety & Outcomes

Advertisement

Comments are closed.